Literature DB >> 20622652

Adverse outcomes in patients with chronic liver disease undergoing colorectal surgery.

Amir A Ghaferi1, Amit K Mathur, Christopher J Sonnenday, Justin B Dimick.   

Abstract

OBJECTIVE: We sought to use a multi-institutional, prospective, clinical database to better understand adverse outcomes in chronic liver disease (CLD) patients undergoing colorectal surgery.
BACKGROUND: CLD confers significant perioperative risk. However, there are little population-based data available for prognostication and risk stratification in these patients.
METHODS: We used data from the 2005-2007 American College of Surgeons National Surgical Quality Improvement Project to study 30,927 patients undergoing colorectal resections. We first identified patients with CLD (n = 1565) with any of the following clinical characteristics: ascites, esophageal varices, or total bilirubin greater than 2 mg/dL. Postoperative complications and mortality rates were then compared between CLD and non-CLD patients.
RESULTS: CLD patients have a nearly 6.5-fold increased risk of mortality following colorectal operations (Relative Risk [RR], 6.53; 3.2% in non-CLD group versus 21.5% in CLD group). Patients with CLD also had significantly higher major complication rates (RR, 2.72; 15.4% vs. 41.9%, respectively). The failure to rescue rate (ie, proportion of deaths following major complications) was also markedly higher in patients with CLD (RR, 2.27; 15.1% vs. 34.2%, respectively). Furthermore, stratification of CLD patients by Model for End-stage Liver Disease (MELD) score demonstrated significantly higher rates of complications (RR, 2.41; 2.31-2.51), failure to rescue (RR, 2.62; 2.35-2.90), and mortality (RR, 8.92; 8.11-9.78) in CLD patients with MELD > or =15 compared with CLD patients with MELD <15.
CONCLUSIONS: Colorectal surgery in CLD patients is associated with significant morbidity and mortality. Furthermore, those who develop major complications have a significantly higher risk of death compared to non-CLD. These very high risks should be discussed at length with patients prior to undertaking major surgical procedures.

Entities:  

Mesh:

Year:  2010        PMID: 20622652     DOI: 10.1097/SLA.0b013e3181e982d6

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  Coexisting liver disease is associated with increased mortality after surgery for diverticular disease.

Authors:  Jonathan Montomoli; Rune Erichsen; Lisa L Strate; Lars Pedersen; Tove Nilsson; Henrik Toft Sørensen
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

2.  Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy.

Authors:  Matthew M Fleming; Fangfang Liu; Yawei Zhang; Kevin Y Pei
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

3.  Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery?

Authors:  Haddon Jacob Pantel; Kristian D Stensland; Jason Nelson; Todd D Francone; Patricia L Roberts; Peter W Marcello; Thomas Read; Rocco Ricciardi
Journal:  J Gastrointest Surg       Date:  2016-05-23       Impact factor: 3.452

4.  Liver Cirrhosis/Severe Fibrosis Is a Risk Factor for Anastomotic Leakage after Colorectal Surgery.

Authors:  Samuel Andreas Käser; Irina Hofmann; Niels Willi; Felix Stickel; Christoph Andreas Maurer
Journal:  Gastroenterol Res Pract       Date:  2016-12-26       Impact factor: 2.260

Review 5.  Perioperative Care of Patients With Liver Cirrhosis: A Review.

Authors:  Naeem Abbas; Jasbir Makker; Hafsa Abbas; Bhavna Balar
Journal:  Health Serv Insights       Date:  2017-02-24

6.  Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.

Authors:  Eon Chul Han; Seung-Bum Ryoo; Ji Won Park; Jin Wook Yi; Heung-Kwon Oh; Eun Kyung Choe; Heon-Kyun Ha; Byung Kwan Park; Sang Hui Moon; Seung-Yong Jeong; Kyu Joo Park
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

7.  Perioperative management of liver surgery-review on pathophysiology of liver disease and liver failure.

Authors:  Lukas Gasteiger; Stephan Eschertzhuber; Werner Tiefenthaler
Journal:  Eur Surg       Date:  2018-04-13       Impact factor: 0.953

Review 8.  Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease.

Authors:  Laura Hickman; Lauren Tanner; John Christein; Selwyn Vickers
Journal:  J Gastrointest Surg       Date:  2018-11-21       Impact factor: 3.452

9.  Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study.

Authors:  Jonathan Montomoli; Rune Erichsen; Christian Fynbo Christiansen; Sinna Pilgaard Ulrichsen; Lars Pedersen; Tove Nilsson; Henrik Toft Sørensen
Journal:  BMC Gastroenterol       Date:  2013-04-15       Impact factor: 3.067

Review 10.  Colorectal surgery in cirrhotic patients.

Authors:  Jacqueline Paolino; Randolph M Steinhagen
Journal:  ScientificWorldJournal       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.